Rituximab for non-infectious Uveitis and Scleritis.
Caleb C NgAileen SyEmmett T CunninghamPublished in: Journal of ophthalmic inflammation and infection (2021)
Overall, RTX appeared to be both effective and well-tolerated as second or third-line therapy for patients with non-infectious uveitis and scleritis.